Modulation of SIRT3 expression through CDK4/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulation of SIRT3 expression through CDK4/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells
Authors
Keywords
-
Journal
BMC CANCER
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-19
DOI
10.1186/s12885-020-06822-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Abemaciclib, a Selective CDK4/6 Inhibitor, Enhances the Radiosensitivity of Non–Small Cell Lung CancerIn VitroandIn Vivo
- (2018) Sarwat Naz et al. CLINICAL CANCER RESEARCH
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway
- (2018) Shaojia Wang et al. ONCOGENE
- SIRT3 activator Honokiol attenuates β-Amyloid by modulating amyloidogenic pathway
- (2018) Sindhu Ramesh et al. PLoS One
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3/SIRT3 signaling pathway in ovarian cancer cells
- (2018) Yufei Yang et al. Cancer Medicine
- SIRT1-SIRT3 Axis Regulates Cellular Response to Oxidative Stress and Etoposide
- (2017) Ilaria Carnevale et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice
- (2017) Vinodkumar B. Pillai et al. Oncotarget
- SIRT3: Oncogene and Tumor Suppressor in Cancer
- (2017) Margalida Torrens-Mas et al. Cancers
- Down-regulation of SIRT3 promotes ovarian carcinoma metastasis
- (2016) Xue-cai Dong et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Palbociclib (PD-0332991), a selective CDK4/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma
- (2016) Julien Bollard et al. GUT
- SIRT3 participates in glucose metabolism interruption and apoptosis induced by BH3 mimetic S1 in ovarian cancer cells
- (2016) Xi-Yan Xiang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Sirtuin 3: A Janus face in cancer (Review)
- (2016) Yanlu Xiong et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Pro-Proliferative Function of Mitochondrial Sirtuin Deacetylase SIRT3 in Human Melanoma
- (2016) Jasmine George et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Sirt1 regulates glial progenitor proliferation and regeneration in white matter after neonatal brain injury
- (2016) Beata Jablonska et al. Nature Communications
- Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies
- (2015) Wei Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SIRT3 protects cells from hypoxia via PGC-1α- and MnSOD-dependent pathways
- (2015) Q. Wang et al. NEUROSCIENCE
- Sirtuin 3 inhibits hepatocellular carcinoma growth through the glycogen synthase kinase-3β/BCL2-associated X protein-dependent apoptotic pathway
- (2015) C-L Song et al. ONCOGENE
- Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection
- (2014) Jia-Xing Wang et al. BMC CANCER
- Decreased mitochondrial SIRT3 expression is a potential molecular biomarker associated with poor outcome in breast cancer
- (2014) Mohamed Mokhtar Desouki et al. HUMAN PATHOLOGY
- The CDK4/6 Inhibitor LY2835219 Overcomes Vemurafenib Resistance Resulting from MAPK Reactivation and Cyclin D1 Upregulation
- (2014) V. Yadav et al. MOLECULAR CANCER THERAPEUTICS
- Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas
- (2013) Misu Lee et al. ACTA NEUROPATHOLOGICA
- SIRT3 expression in hepatocellular carcinoma and its impact on proliferation and invasion of hepatoma cells
- (2013) Bo Zhang et al. Asian Pacific Journal of Tropical Medicine
- SIRT3 Is a Mitochondrial Tumor Suppressor: A Scientific Tale That Connects Aberrant Cellular ROS, the Warburg Effect, and Carcinogenesis
- (2012) M. C. Haigis et al. CANCER RESEARCH
- Second-Line Therapies in Hepatocellular Carcinoma: Emergence of Resistance to Sorafenib
- (2012) A. Villanueva et al. CLINICAL CANCER RESEARCH
- Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update
- (2012) Angela Gauthier et al. HEPATOLOGY RESEARCH
- Low SIRT3 Expression Correlates with Poor Differentiation and Unfavorable Prognosis in Primary Hepatocellular Carcinoma
- (2012) Chris Zhiyi Zhang et al. PLoS One
- SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization
- (2011) Lydia W.S. Finley et al. CANCER CELL
- Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib
- (2011) Jae Hoon Lee et al. LIVER INTERNATIONAL
- Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer
- (2010) Turki Y. Alhazzazi et al. CANCER
- SIRT3 Is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integrity and Metabolism during Stress
- (2010) Hyun-Seok Kim et al. CANCER CELL
- Proliferative Suppression by CDK4/6 Inhibition: Complex Function of the Retinoblastoma Pathway in Liver Tissue and Hepatoma Cells
- (2010) Dayana B. Rivadeneira et al. GASTROENTEROLOGY
- Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling
- (2010) Eric Verdin et al. TRENDS IN BIOCHEMICAL SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now